Tag: biosimilars
Biosimilars Are Making Inroads In U.S., But It’s Still A Bumpy Ride
Biosimilars are gaining traction as cost-effective alternatives to branded reference drugs in the United States. These products offer…
Healthcare Inc.: Insurer coverage of Humira, biosimilars
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in…